EXELON (rivastigmine tartrate) capsules 1.5, 3.0, 4.5, 6.0 mg

Mfg: Novartis

Indication(s):  Treatment of mild to moderate dementia of the Alzheimer's type.

Administration:  Starting dose is 1.5mg orally twice daily.  After 2 weeks, if tolerated, dose may be increased to 3mg orally twice daily.  Maximum dose is 6mg orally twice daily (12mg/day).

Pharmacology:  It is postulated that Exelon facilitates cholinergic neurotransmission across pathways that project from the basal forebrain to the cerebral cortex and hippocampus by increasing the availability of acetylcholine by inhibiting its breakdown by cholinesterase.  (i.e. acetylcholinesterase inhibitor)

WebRx Editorial Notes:  

2000 WebRx Pharmacy Palace